A SIMPLE KEY FOR HEMGENIX UNVEILED

Quantity of eligible individuals: CDEC talked over the uncertainty in the number of people with moderately severe to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical experts consulted by CADTH indicated that some clients who are classified as getting gentle or moderate condition can have a serious bleeding phenotype,